Objekt-Metadaten

The efficacy of isolated bacteriophages from pig farms against ESBL/AmpC-producing Escherichia coli from pig and Turkey farms
Skaradziska, Aneta ;  Sliwka, Paulina ;  Kuzminska-Bajor, Marta ;  Friese, Anika ;  Roschanski, Nicole ;  Murugaiyan, Jayaseelan ;  Roesler, Uwe H.

HaupttitelThe efficacy of isolated bacteriophages from pig farms against ESBL/AmpC-producing
Escherichia coli from pig and Turkey farms
AutorSkaradziska, Aneta
AutorSliwka, Paulina
AutorKuzminska-Bajor, Marta
AutorFriese, Anika
AutorRoschanski, Nicole
AutorMurugaiyan, Jayaseelan
AutorRoesler, Uwe H.
Seitenzahl7 S.
Freie Schlagwörterbacteriophages; antibiotic resistance; antibiotic resistance genes; ESBL/AmpC resistant E. coli; phage therapy
DDC630 Landwirtschaft, Veterinärmedizin
Auch erschienen inFrontiers in Microbiology. - 8 (2017), Artikel Nr. 530
ZusammenfassungExtended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases are plasmid (but also chromosomally) encoded enzymes found in Enterobacteriaceae, determining resistance to a variety of important antibiotics including penicillins, cephalosporins, and monobactams. In recent decades, the prevalence of ESBL/AmpC-producing bacteria has increased rapidly across the world. Here, we evaluate the potential use of bacteriophages in terms of a reduction of antibiotic-resistant bacteria in healthy animals. The aim of our studies was to isolate bacteriophages capable of destroying ESBL/AmpC-producing Escherichia coli isolated from livestock habitats. The efficacy of isolated phages against ESBL/AmpC E. coli strains varies, but creation of a phage cocktail with broad activity spectrum is possible. This may indicate that the role of phages may not be limited to phage therapy, but bacterial viruses may also be applied against spread of bacteria with antibiotic resistance genes in the environment. We also addressed the hypothesis, that phages, effective for therapeutic purposes may be isolated from distant places and even from different environments other than the actual location of the targeted bacteria. This may be beneficial for practical purposes, as the construction of effective phage preparations does not require access to disease outbreaks.
Dokumente
PDF-Datei von FUDOCS_document_000000026966
Falls Ihr Browser eine Datei nicht öffnen kann, die Datei zuerst herunterladen und dann öffnen.
 
Fachbereich/EinrichtungFB Veterinärmedizin
Erscheinungsjahr2017
Dokumententyp/-SammlungenWissenschaftlicher Artikel
SpracheEnglisch
RechteCreative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Anmerkungen des AutorsDer Artikel wurde in einer reinen Open-Access-Zeitschrift publiziert.
Erstellt am08.05.2017 - 09:48:28
Letzte Änderung08.05.2017 - 09:49:32
 
Statische URLhttp://edocs.fu-berlin.de/docs/receive/FUDOCS_document_000000026966
DOI10.3389/fmicb.2017.00530
Zugriffsstatistik
 

LOADING...